Skip to main content

Gilead Sciences, Inc.

SEC CIK
0000882095
Latest filing
Aug 3, 2026

Holdings in Q2 2025

Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.

Institution overview
Positions
14
0 vs. Q1 2025
Portfolio value
$1.28B
+$98.9M (+8.4%) vs. Q1 2025
Filed
Aug 14, 2025
SEC
Holdings of Gilead Sciences, Inc. in Q2 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
LKFTLakefront Biotherapeutics NVSPON ADR16,707,477$467.6M36.5%00.0%UnchangedHistory
ACLXArcellx, Inc.COMMON STOCK6,720,803$442.6M34.6%00.0%UnchangedHistory
RCUSArcus Biosciences, Inc.COM31,424,760$255.8M20.0%00.0%UnchangedHistory
ASMBAssembly Biosciences, Inc.COM NEW2,209,471$40.0M3.1%00.0%UnchangedHistory
TNGXTango Therapeutics, Inc.COM4,854,443$24.9M1.9%00.0%UnchangedHistory
MRUSMerus N.V.COM452,527$23.8M1.9%00.0%UnchangedHistory
KYTXKyverna Therapeutics, Inc.COM4,126,119$12.7M1.0%00.0%UnchangedHistory
XLOXilio Therapeutics, Inc.COM9,105,451$6.19M0.5%00.0%UnchangedHistory
HOOKHOOKIPA Pharma Inc.COM1,875,945$2.35M0.2%00.0%UnchangedHistory
CYPHCypherpunk Technologies Inc.COM NEW5,319,148$1.58M0.1%00.0%UnchangedHistory
ALLOAllogene Therapeutics, Inc.COM1,156,689$1.31M0.1%00.0%UnchangedHistory
KLRSKalaris Therapeutics, Inc.COM317,789$848.5K0.1%−405,484−56.1%ReducedHistory
IMAImageneBio, Inc.COM348,534$467.1K<0.1%−810,611−69.9%ReducedHistory
BRNSBarinthus Biotherapeutics plc.ADS99,478$92.5K<0.1%−270,377−73.1%ReducedHistory